Central Retinal Artery Occlusion Clinical Trial
Official title:
A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion
The aim of the THEIA study is to determine if Alteplase administrated within 4.5 hours improve visual deficit due to acute CRAO with a good safety profile.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A | |
Recruiting |
NCT04526951 -
TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)
|
Phase 3 | |
Recruiting |
NCT04965038 -
Early Reperfusion Therapy With Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion
|
Phase 3 | |
Recruiting |
NCT01348633 -
Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye
|
N/A | |
Recruiting |
NCT05562284 -
Safety and Efficacy After Selective Intra-arterial Thrombolysis for Central Retinal Artery Occlusion
|
N/A | |
Completed |
NCT05739487 -
Changes of Visual Field Defects After IAT for CRAO
|
||
Completed |
NCT03049514 -
Study of Arterial Recanalization of the Central Retinal Artery Occlusions
|
||
Terminated |
NCT00802698 -
The Effect of Transcorneal Stimulation in Cases of Central Retinal Artery Occlusion Using a New Waveform
|
N/A | |
Recruiting |
NCT06178055 -
A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arthritic Central Retinal Artery Occlusion (CRAO)
|
Phase 2 |